Dexco S.A. (BVMF:DXCO3)
Brazil · Delayed Price · Currency is BRL 4.760
-0.030 (-0.63%)
May 29, 2026, 5:07 PM GMT-3
Dexco Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,365 | 8,249 | 8,235 | 7,383 | 8,487 | 8,170 | |
Revenue Growth (YoY) | 1.99% | 0.17% | 11.53% | -13.00% | 3.87% | 38.96% |
Cost of Revenue | 6,350 | 6,348 | 6,273 | 5,776 | 6,213 | 5,430 |
Gross Profit | 2,015 | 1,901 | 1,962 | 1,607 | 2,274 | 2,740 |
Selling, General & Admin | 1,516 | 1,530 | 1,545 | 1,428 | 1,459 | 1,310 |
Other Operating Expenses | -150.26 | -152.91 | 4.14 | -42.19 | 17.85 | -400.37 |
Operating Expenses | 1,365 | 1,377 | 1,550 | 1,386 | 1,477 | 909.85 |
Operating Income | 649.46 | 523.92 | 412.22 | 221.28 | 796.76 | 1,831 |
Interest Expense | -982.04 | -917.18 | -776.81 | -1,061 | -916.07 | -306.19 |
Interest & Investment Income | 259.4 | 215.17 | 264.28 | 543 | 384.39 | 403.86 |
Earnings From Equity Investments | 177.68 | 222.7 | -72.9 | 279.78 | 54.59 | -68.61 |
Currency Exchange Gain (Loss) | -163.57 | -168.26 | -37.77 | - | - | - |
Other Non Operating Income (Expenses) | 39.1 | 41.76 | -41.76 | - | - | - |
EBT Excluding Unusual Items | -19.98 | -81.9 | -252.74 | -17.35 | 319.68 | 1,860 |
Merger & Restructuring Charges | -220.23 | -220.23 | -30.34 | - | - | - |
Gain (Loss) on Sale of Investments | -27.74 | -27.17 | -32.23 | - | - | - |
Gain (Loss) on Sale of Assets | 37.15 | 37.15 | 52.68 | - | - | - |
Asset Writedown | 187.96 | 199.39 | 518.14 | 768.59 | 597.87 | 129.44 |
Other Unusual Items | 4.56 | 4.56 | 88.96 | - | - | - |
Pretax Income | -38.28 | -88.21 | 344.47 | 751.25 | 917.55 | 1,989 |
Income Tax Expense | -114.64 | -151.27 | 170.1 | -60.02 | 152.62 | 263.38 |
Earnings From Continuing Operations | 76.36 | 63.07 | 174.38 | 811.27 | 764.92 | 1,726 |
Minority Interest in Earnings | -67.77 | -61.88 | -1.96 | -21.67 | -9.06 | -0.28 |
Net Income | 8.59 | 1.18 | 172.41 | 789.6 | 755.86 | 1,725 |
Net Income to Common | 8.59 | 1.18 | 172.41 | 789.6 | 755.86 | 1,725 |
Net Income Growth | -96.67% | -99.31% | -78.16% | 4.46% | -56.19% | 280.20% |
Shares Outstanding (Basic) | 916 | 916 | 905 | 905 | 915 | 776 |
Shares Outstanding (Diluted) | 919 | 918 | 908 | 908 | 918 | 781 |
Shares Change (YoY) | 1.06% | 1.10% | 0.05% | -1.11% | 17.59% | -17.09% |
EPS (Basic) | 0.01 | 0.00 | 0.19 | 0.87 | 0.83 | 2.22 |
EPS (Diluted) | 0.01 | 0.00 | 0.19 | 0.87 | 0.82 | 2.21 |
EPS Growth | -96.71% | -99.32% | -78.18% | 5.63% | -62.74% | 358.55% |
Free Cash Flow | 405.6 | -60.32 | -44.88 | 177.26 | -354.23 | 910.96 |
Free Cash Flow Per Share | 0.44 | -0.07 | -0.05 | 0.20 | -0.39 | 1.17 |
Dividend Per Share | - | - | - | 0.192 | - | 0.945 |
Dividend Growth | - | - | - | - | - | 307.33% |
Gross Margin | 24.09% | 23.04% | 23.82% | 21.77% | 26.79% | 33.54% |
Operating Margin | 7.76% | 6.35% | 5.01% | 3.00% | 9.39% | 22.41% |
Profit Margin | 0.10% | 0.01% | 2.09% | 10.69% | 8.91% | 21.12% |
Free Cash Flow Margin | 4.85% | -0.73% | -0.55% | 2.40% | -4.17% | 11.15% |
EBITDA | 1,815 | 1,667 | 1,535 | 1,387 | 1,642 | 2,543 |
EBITDA Margin | 21.69% | 20.21% | 18.64% | 18.78% | 19.35% | 31.12% |
D&A For EBITDA | 1,165 | 1,143 | 1,123 | 1,166 | 845.45 | 712.29 |
EBIT | 649.46 | 523.92 | 412.22 | 221.28 | 796.76 | 1,831 |
EBIT Margin | 7.76% | 6.35% | 5.01% | 3.00% | 9.39% | 22.41% |
Effective Tax Rate | - | - | 49.38% | - | 16.63% | 13.24% |
Advertising Expenses | - | 191.3 | 187.75 | - | - | - |